A Stochastic Economic Evaluation of Letrozole versus Tamoxifen as a First-Line Hormonal Therapy: For Advanced Breast Cancer in Postmenopausal Patients

Author： Karnon J.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.21, Iss.7, 2003-01, pp. : 513-525

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tamoxifen Plus Chemotherapy versus Tamoxifen Alone as Adjuvant Therapies for Node-Positive Postmenopausal Women with Early Breast Cancer: A Stochastic Economic Evaluation

By Karnon J.   Brown J.  

PharmacoEconomics, Vol. 20, Iss. 2, 2002-02 ,pp. : 119-137

Adis International

Access to resources Recommend Favorite

Anastrozole: first-line therapy for advanced breast cancer?

By  

Inpharma, Vol. 1, Iss. 1270, 2001-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Letrozole superior to tamoxifen in advanced breast cancer

By  

Inpharma, Vol. 1, Iss. 1324, 2002-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Capecitabine combined with docetaxel versus vinorelbine followed by capecitabine maintenance medication for first-line treatment of patients with advanced breast cancer: Phase 3 randomized trial

By  

Cancer, Vol. 121, Iss. 19, 2015-10 ,pp. : 3412-3421

Blackwell Publishing

Access to resources Recommend Favorite

Paclitaxel in a novel formulation containing less Cremophor EL as first-line therapy for advanced breast cancer: A phase II trial

By Ta-Chung Chao   Zyting Chu   Ling-Ming Tseng   Tzeon-Jye Chiou   Ruey-Kuen Hsieh   Wei-Shu Wang   Chueh-Chuan Yen   Muh-Hwa Yang   Liang-Tsai Hsiao   Jin-Hwang Liu   Po-Min Chen  

Investigational New Drugs, Vol. 23, Iss. 2, 2005-01 ,pp. : 171-177

Springer Publishing Company

Access to resources Recommend Favorite